Nicholas Company’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-104,919
Closed -$2.55M 219
2024
Q4
$2.55M Hold
104,919
0.04% 212
2024
Q3
$3.9M Hold
104,919
0.06% 206
2024
Q2
$5M Hold
104,919
0.08% 191
2024
Q1
$4.02M Hold
104,919
0.07% 203
2023
Q4
$3.27M Hold
104,919
0.06% 206
2023
Q3
$4.22M Hold
104,919
0.08% 197
2023
Q2
$5.52M Hold
104,919
0.11% 187
2023
Q1
$6.71M Sell
104,919
-8,506
-7% -$555K 0.14% 163
2022
Q4
$5.51M Buy
113,425
+8,400
+8% +$527K 0.12% 179
2022
Q3
$7.41M Hold
105,025
0.17% 134
2022
Q2
$7.45M Buy
105,025
+41,850
+66% +$2.7M 0.16% 149
2022
Q1
$5.05M Buy
+63,175
New +$4.7M 0.09% 213

Other funds holding STAA

Nicholas Company's STAA Position: Q1 2025 in Review

Nicholas Company sold out of STAAR Surgical (STAA) in Q1 2025, closing a stake of 104,919 shares — an estimated $2.55M sold.

Nicholas Company first reported a position in STAA in Q1 2022 and held it in 12 quarters. The position peaked at $7.45M in Q2 2022. 185 funds tracked by Wall St. Rank hold STAA as of Q1 2025.

  • Nicholas Company reported no remaining STAAR Surgical position as of Q1 2025 after selling out during the quarter.
  • Nicholas Company sold 104,919 STAAR Surgical shares in Q1 2025, an estimated $2.55M.
  • Nicholas Company first reported a position in STAAR Surgical in Q1 2022 and held it in 12 quarters.
  • Nicholas Company's STAAR Surgical position peaked at $7.45M in Q2 2022.
  • 185 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2025.

Based on Nicholas Company's 13F filing for Q1 2025, filed 8 May 2025.